We examine some simple mathematical models which have been recently employed to predict the evolution of population dynamical systems involving virus particles. They include: (1) A general two-component antibody-viral system; (2) A simplified twocomponent model for HTV-1 dynamics (3) An HTV-1 three-component model including virions and (4) A four-component HTV-1 dynamical model which includes both latently and actively infected cells. For each system we find equilibrium points and analyse their local stability properties in order to obtain a global phase portrait Analytical methods are complemented with numerical solutions. In all four models there are at most two equilibrium points for physically meaningful values of the variables. As the viral growth rate parameter increases through a critical value, a transcritical bifurcation occurs. One critical point (P\) is always found at zero viral or infected cell levels and non-zero antibody or uninfected cell levels. For parameter values in their usual ranges, P\ is either an asymptotically stable node or a saddle point When the critical point Pi occurs at biologically meaningful values, it is either an asymptotically stable node or an asymptotically stable spiral point For all three HTV-1 models, the values of the parameters at which P% makes a transition to physically meaningful values are precisely those at which P\ changes from an asymptotically stable node to an unstable saddle point The global pictures for all four models are similar and examples are represented graphically. No limitcycle solutions were found in any of the models for parameter values in their usual ranges. In the four-component HTV-1 model, the effects of varying each parameter are found and conditions under which Pj changes from spiral point to node are investigated numerically. The effects of reverse transcriptase inhibitors and protease inhibitors, two classes of drugs used to treat HTV-1 infection, are examined in the three-component model for early HTV-1 dynamics.
Introduction
The importance of dynamical mathematical models of viral-antibody systems has been emphasized recently in many theoretical studies of the growth of HTV-1 populations in infected hosts. Tlie models employed vary from reduced two-component models such as those employed by Bonhoeffer et aL (1997) , to more complete three-component models (Herz et aL, 1996) and four-component models (McLean et al., 1991; Phillips, 1996; Nowak & Bangham, 1996; Perelson et aL, 1996 Perelson et aL, , 1997 Tuckwell & Le Corfec, 1998) . One important application (see Section 6 of this article) has been to ascertain the effects of various drug treatments, such as reverse transcriptase inhibitors and protease inhibitors (Kirschner & Webb, 1996; Wein et al., 1997 Wein et al., , 1998 .
Most of the above studies involve the numerical solution of systems of non-linear ordinary differential equations. However, a useful supplement to such a numerical approach is the analysis of the nature of the various equilibrium points for various ranges of values of the parameters. Such analysis provides insight into the nature of solutions without numerical solution. In this note we summarize the results of such an analysis for some simple models of viral-immune system population dynamics. These results are also useful in the synthesis and analysis of spatial epidemic network models in which viral or other noxious particles are transmitted between individuals within a population (Tuckwell etal, 1998 (Tuckwell etal, ,2000 .
We shall perform a partly analytical investigation of models with up to four components, deemed by some authors appropriate for early dynamics. However, despite the above and more recent mathematical models, there is still uncertainty as to the mechanisms underlying the time course of the variable of primary interest, namely the viral load. During the initial stages of HIV infection, the viral load in plasma increases, reaches a maximum, and then decresaes. Phillips (1996) supposed that the decline is due to a limited number of cells susceptible to HTV infection. However, Stafford et al. (2000) developed models of primary HTV-1 infection, and compared the results with data on infected patients. The data were consistent with a target-cell-limited model until shortly after the peak in viremia, but in some patients, not during the subsequent fall and recovery in virus concentration. It was suggested that some additional process, perhaps mediated by CD8+ T cells, is important in at least some patients. Cogent mathematical investigations of the effects of drug treatments, especially in the long term, require models which can satisfactorily predict the time course of both viral load and CD4+ T-cell numbers in the absence of treatment Such models seem to require more variables than those considered in the present article. For example, Wein et aL (1997 Wein et aL ( , 1998 , in their quest for optimal drug regimes, introduced extra variables for wild-type and mutant virus strains and for long-lived infected CD4+ T-cells. In our analysis of the three-component HTV-1 model under chemotherapy we only consider one viral strain and only have one compartment for uninfected cells. With this restricted model we are able to find exact outcomes for various combinations of reverse transcriptase and protease inhibitors. We do not include (cf. Fraser et aL, 2000) any drug that produces T-cell activation, such as interleukin-2; these authors have demonstrated that greater doses of such a drug may sometimes give rise to a negative result-
General two-component effector-virus system
The following is a very simple model (Anderson & May, 1991) which may be considered to be a paradigm system for many virus-effector populations. Although it omits details of the immune response, it captures the essence of immune system attack on disease-causing particles, thus providing some insight into the properties of more complicated realistic models. Let a{t) and v(t) be the numbers or densities of effectors and virus, respectively, at time t. In this model, effectors (here defined as any agent which acts to eliminate a virus) are produced at a rate s, assumed constant, die at a per capita rate /A, and are produced at a rate eav by interaction with the viral population. Hence da -= s -\ia + eav.
(1) at Viral particles have an intrinsic per virion production rate r and are removed at rate yav by effectors so that dv -=rv-yav.
(2) at All the parameters are non-negative as are the variables a and v. In the system (1) and (2), for any value of s, there are two critical points (steady state solutions) at Pi = (^,0) and P 2 = (I, i££z£21). 
The nature of P2
The eigenvalues associated with P2 are
If s = 0 the eigenvalues are k\ = -iy/Jir and A. 2 = iJW, so that P2 is a center. If sy > fir, then A.] < 0 < A. 2 so that P2 is an unstable saddle point If sy < fir, then there are two distinct possibilities.
(a) j^-plfir -ys] < 1-In this case, the eigenvalues are distinct and negative, which makes P2 an asymptotically stable node. (b) T^-j[/ir -ys] > 1-The eigenvalues are then a complex conjugate pair with a negative real part Hence P2 is an asymptotically stable spiral point Note that for the singular case, in which fir = ys, the nature of P2 will have to be determined by consideration of non-linear effects of the system.
Discussion and phase portrait
CASE 1 Firstly we observe that if sy > \ir, the point P2 occurs at negative v and is hence is not at a biologically relevant value. There is then just one meaningful critical point P\ on the a-axis and this is an asymptotically stable node. Thus no matter where solutions start in the non-negative quadrant, they approach Pi with zero virions and with a(oo) = -effectors.
CASE 2 When sy < fir, there is an unstable saddle point on the a-axis at Pi together with an equilibrium point Pi in the positive quadrant which is either an asymptotically stable node or an asymptotically stable spiral point Then whenever the initial value u(0) is positive, regardless of whether a(0) is positive or zero, the system ends up at P2. Thus in such cases it is impossible to end up with zero virions; an equilibrium is approached with £• effectors and ^~'^ virions. If 5 is relatively small, the solutions undergo damped oscillations on their approach to P2; if s is large enough solutions show no oscillatory behavior and proceed directly to PiNote that at the critical value sy = rfi where there is a change of stability of P\ and P2, the two critical points coincide, both being located at (^, 0) with P2 emerging as the asymptotically stable steady state for ^ < £. Thus, there is a transcritical bifurcation, with Pt emerging as ^ decreases below -. The distinction between the two cases of either one or two equilibria can be most clearly understood by noting that they arise when s/fi > r/y and s/fi < r/y respectively. These are relations between the relative strength of effector persistence (s/fi) and the corresponding quantity for virions (r/y). If s is very small and positive the predator-prey case of periodic solutions is manifest by the oscillatory nature of the solutions. However, as is expanded on elsewhere (Tuckwell & Wan, 2000) , in no case for the two-component virus-antibody model for one individual, are there limit cycle solutions.
The various possibilities for this model are sketched in Figure 1 . In the top part, with sy > fir, the paths all end up at the asymptotically stable node on the a-axis. In the middle and bottom figures we have sy < fir, and solutions either spiral towards the positive critical point (middle part) or approach the critical point, now a node, along a line parallel to the u-axis.
Two-component model for HTV-1 dynamics
We will consider more complete models for HTV-1 population dynamics below but first analyse a simplified model introduced by Bonhoeffer et aL (1997) . Here there are two components: x, the number of uninfected CD4+ T-cells and y, the number of infected such cells. Then the following two equations describe the evolution of the system:
where again all parameters and variables are non-negative. Again s is the assumed constant rate of production of CD4+ T-cells, fi is their per capita death rate, kxy is the rate of infection of CD4+ T-cells by virus, and ay is the rate of disappearance of infected cells. The viral variable has been omitted for simplicity as it is here assumed to be linearly related to y. It can be seen that (3) and (4) are of the same form as (1) and (2) If s > 0 there are the following cases. If sk < fia, both eigenvalues are negative and Pi is an asymptotically stable node. If sk > fia, one eigenvalue is negative and the other is positive so that Pi is a saddle point (unstable). At the critical value sk = afi when a change of stability of the uninfected state Pi as well as the endemically infected state Pi occurs, we have Pj = (f, jt^) = (£, 0) = Pi so that the two states coincide. Hence, at the critical value sk = na, there is a transcritical bifurcation with the endemically infected state Pi emerging for sk > a\L. (This is the two-component counterpart of the four component case analysed by Perelson et aL (1993) where he coined the term endemically infected state for Pi.) With dy/df = 0 for y = 0, the unrealistic state Pi (when sk < ctfi) cannot be reached from any initial state in the first quadrant. Hence, we only need to be concerned with the stability of Pi for sk > a\i.
The nature of Pi
For Pi the associated eigenvalues are ks
ks \ ks
In those cases where Pi is biologically meaningful (sk ^ afi), we have 0 ^ 1 -^ < 1 and there are two possibilities.
(a) -^ry [ks-ctfi] > 1 • Then the eigenvalues are complex conjugates with negative real part, making Pi an asymptotically stable spiral point (b) jjifpiks -afi] < 1-In this case the eigenvalues are both real and negative so that
Pi is an asymptotically stable node.
Discussion and phase portrait CASE 1 sk < or//.. Here there is one biologically meaningful critical point Pi on the x-axis (since y cannot be negative). Then for any non-negative s this critical point is an asymptotically stable node. Trajectory analysis shows that solutions which start in the positive quadrant must remain there. Thus for any combination of initial numbers of uninfected (x) and infected CD4+ T-cells, the infected cell population is eventually totally eliminated.
CASE 2 sk > afi. There are two critical points. Pi is on the x-axis and Pi is in the non-negative quadrant When sk > afi, P\ is always an unstable saddle point and Pi is either an asymptotically stable spiral point (case (a) above), or an asymptotically stable node (case (b)). For any initial values the solution eventually approaches the equilibrium point Pi, either with damped oscillatory motion or by direct approach; thus eventually there is present an equilibrium mixture of both uninfected and infected cells. The various possibilities are similar in qualitative detail to those shown in Figure 1 .
Three-component early HlV-1 model with virions
A more complete model of human immunodeficiency virus type 1 (HTV-1) dynamics considers in addition to the uninfected and infected CD4-f T-cells, x and y respectively, the number of virions in plasma, v. The following three equations are a slightly modified version of those in Herz et aL (1996) :
The third equation in the last mentioned reference does not contain the term -kvx to account for the fact that when a virus infects a CD4+ T-cell, v decreases at the same time as x decreases. Without this we have just dt> -=cy-yv
Here c is the rate at which infected cells emit virions.
For (5), (6) and either (7) or (7A) we find a critical point at Pi = (£,0,0). For the model with (7) we find a second critical point at Pi -(^c-a S» I ~~ Icic-a) < '^ay^ ~ %)• On the other hand for the model with (7A), the second critical point is at P' = (££ L -ZM. £2. _ M) T 0 see now great a difference there is between the model with (7) and that with (7A), we compute the coordinates of the critical points with the following representative parameter values which we refer to as standard. These values and those of the next section are taken from Phillips (19%): so that the eigenvalues may be accurately found by numerical solution. For the standard set of parameters given above, it is found that the eigenvalues are k\ = -2-3438, A.2,3 = -00025 ± 00342i so that Pi is an asymptotically stable spiral point More generally, for any given set of positive input parameter values, the coefficients a, S and € 2 are all positive. In addition it is straightforward to verify that aS -e 2 is always positive. The Routh-Hurwitz necessary and sufficient criteria (of a > 0, e 2 > 0 and aS -e 2 > 0) for all three roots of the cubic equation for k to have a negative real part are satisfied. Hence P 2 is always asymptotically stable.
Effects of variations in s
When s is varied from 50% below the standard value to 50% above it, and the other parameters are kept at their standard values, the equilibrium point P2 remains an asymptotically stable spiral point. This is also the case when s is decreased to the critical value *(c -a) at which P2 becomes unphysical and when s is increased by as much as a factor of 10. When s is decreased below s c , solutions approach the asymptotically stable node at Pi where there are zero virions and zero infected cells.
Effects of variations in the remaining parameters
On varying the remaining five parameters (a, c, y, k, /x) one at a time to 50% above and below their standard values, while keeping all the remaining parameters at their standard values, the nature of P 2 remained unchanged as an asymptotically stable spiral point 
Discussion and phase portrait
The behavior of solutions in the three-component HTY-1 model is similar to that for the two-component model. There are at most two critical points and one of these (ft) may occur at unphysical values of the variables y and v. We note that the condition that ft occurs at physical values, i.e. ay < fa^~a^, is precisely the necessary and sufficient condition for Pi to be an unstable saddle point; otherwise ft is at physically unmeaningful values and Pi is an asymptotically stable node. The computed solution for the standard parameter values given above is shown in Figure 2 . Part a of this figure shows the virion density for the first 50 days after infection whereas part b shows the behavior for later times. The damped oscillations of virion density are apparent as Pi is approached, although it is pointed out that the model is only designed to represent the early response period.
For parameter values varying over considerable ranges about the standard values, numerical computations indicate that there are two main types of behavior for the solutions. CASE (1). P\ is an asymptotically stable node and Pi is at unphysical values with y and v bodi negative. Analysis of direction fields shows that solutions which start in the positive octant remain there. Thus, no matter where solutions start in the (x, y, v) positive octant, they approach the equilibrium point P\ with zero infected cells, zero virions and û ninfected activated CD4+ T-cells. CASE (2). P\ is an unstable saddle point and Pi, at physical values is an asymptotically stable spiral point The latter may be ascertained by using perturbation analysis and is the case for the standard set of parameters and all variations of them which put Pi at physical values. In this case all solutions show damped oscillations as they approach Pi. For any given set of positive input parameter values, the two critical points coalesce at (^, 0,0) at the critical value ayfi = ks(c -a) (that is, s -s c ). As ks(c -a) increases above ayfi. Pi emerges as the asymptotically stable steady state for ks(c -a) > ay/i, and P\ becomes unstable. Thus there is a transcritical bifurcation with the endemically infected state emerging for s > s c .
Four-component HIV-1 dynamical model with latently infected CD4+ T-cells
The following system has been employed (Tuckwell & Le Corfec, 1998) as the basis for a stochastic differential equation model for early HIV-1 dynamics. It differs from the system employed by Phillips (1996) , which was in turn adopted from McLean et aL (1991) , only in that it includes in the virus equation a term for the interaction of virus and uninfected CD4+ T-cells. We have~=
The variables are: x, the number of (activated) uninfected CD4+ T-cells; v, the number of actively infected (i.e. virus-producing) such cells; z, the number of latently (i.e. not yet producing virus) infected cells; and v, the number of virions. These quantities may refer to whole blood (about 5 x 10 6 mm 3 ) or be given for 1 mm 3 of plasma. The parameters are as follows:
s is the rate of arrival (or production) of uninfected CD4+ T-cells in plasma; /i is their death rate per cell; k is the interaction parameter for virus-activated CD4+ T-cell reactions; p is the fraction of uninfected cells that upon infection become latent; a is the rate per cell at which latently infected cells become actively infected; a is the death rate per cell of actively infected CD4+ T-cells; c is the net rate of virion production per actively infected cell; and y is the death rate of free virus particles.
Standard parameters, in addition to those given for the three-component model, are a = 0036 /day/mm 3 , and p = 01, these also being taken from Phillips (1996) . Setting the four derivatives (8)-(l 1) to zero, we obtain two equilibrium points. The first is Pi = (£, 0,0,0) and we let the second be Pi = (x 2 , yi, z 2 , V2> Then, . These values agree with those obtained for very large / by numerical solution of (8) Since A is always positive (for any set of positive parameter values), it follows from the Routh-Hurwitz criteria (A > 0, C > 0 and AB -C > 0), that the three roots of the cubic equation for X all have negative real parts (with the remaining eigenvalue X \ already having been found to be -^). Hence the critical point P\ is asymptotically stable whenever it is the only physically realizable critical point
At the critical value, ^ = X2, the two critical points Pi and Pi coincide at (^, 0,0,0). It is deduced from numerical solutions for the fourth order system of ODEs (8>-(12) that if £ > X2, then P2 is either an asymptotically stable node or an asymptotically stable spiral point In that case we again have a transcritical bifurcation at ^ = X2 with P2 emerging as the asymptotically stable steady state as ^ increases beyond X2-The situation is similar to that of another four-component model considered by Perelson et aL (1993) . That model corresponds to the present one with p = 1 but with the additional feature of logistic growth of the uninfected CD4+ T-cells. In that model P2 was found to be unstable in some parameter regimes. We expect that the stability of P2 is similar in our model and report the results of numerical experiments for different ranges of values of the various parameters.
Effects of varying the parameters
Setting the parameters at the above standard values but putting c = 100 as in Phillips (1996) , Pi is unchanged and Pi = .The natures of Pi and P2 are unchanged, but the peak virion density is about 4500/mm 3 at about 23 days after exposure to the virus. This may be compared with the maximum value of v of about 1440/mm 3 at about 44 days when c = 50. Relative to this standard set, i.e. s = 0-272, fi = 000136, k = 000027, a = 0-33, c = 100, y = 20, a = 0036, p = 01 we have varied each parameter in turn to 50% above and below its standard values. These ranges may be conservative for some parameterssee Perelson et aL (19%) for the standard deviations of some. The results of varying each parameter are as follows.
Increases in 5, k and c and decreases in /z, a and y increased the magnitude of the peak virion level dramatically and shifted the time of peak to smaller values (with converse effects for changes in the opposite direction). For such changes, the smallest time to peak of 14 days occurred with \i reduced to 50% of standard value, the maximum being about 10 600 virus particles per mm 3 . With the changed values of s, /z, k or c, whether up or down by 50%, the point P2 remained a spiral point However, when either a or y were decreased by 50%, the nature of P2 changed to an asymptotically stable node. Furthermore, as k was increased to several times its standard value, the peak for v grew and occurred faster until at five times the standard value, Pj became an asymptotically stable node; the peak then occurred at 7-5 days.
Changes in the parameters a and p had less significant effects with P2 remaining a spiral point Changes in a to 50% above or below the standard value resulted in practically no change in either the maximum virion level nor its time of occurence; corresponding changes in p had similar, but slightly greater, effects.
Effects of certain drug treatments
Mathematical models for viral population dynamics can be used to analyse the effects of drug treatments through the changes in parameters induced by the drugs. In the treatment of HTV-1 infected patients, we will concentrate attention on the effects of reverse transcriptase inhibitors and of protease inhibitors. The first class of drugs, typified by AZT (zidovudine), disables the process of infection of CD4+ T-cells by the virus; the second class block the production of new infectious virus by already infected cells so that only non-infectious virions are generated. These same two drug treatments were considered in a 10-component model by Wein et aL (1997) . Subsequently, Wein et aL (1998) analysed the transient and steady-state behaviors of a mathematical model of HIV-1 dynamics in vivo in order to predict whether combinations of antiretroviral agents could eradicate HTV-1 or maintain viral loads at low levels. They included two cell types (CD4+ T cells and a long-lived pool of cells), two strains of virus (drug-sensitive wild type and drug-resistant mutant) and two types of antiretroviral agents (reverse transcriptase and protease inhibitors). The present mathematical model is similar but only includes one viral and only a plasma compartment, resulting in a more straightforward analysis which complements that of Wein et aL (1998) and of Ferguson et aL (1999) . Thus we will only consider the effects of the same combination treatment in the three-component model of HTV-1 dynamics given by equations (5)-(7). The reverse transcriptase inhibitor changes the infection rate from k to (1 -r)k, where r is the effciency of the drug, being the fraction of infections that are blocked The value of r will generally depend upon the dose schedule and hence be a function of time. Here we assume that r is constant. The protease inhibitor divides the viral population into infectious virions, whose density we let be vj and non-infectious particles, with density VNI-Suppose now that the drug treatment commences at t = to. Then for t < to the model equations are simply (5M7) with v replaced by u/. For t > to we have, letting the fraction of newly produced virus particles rendered non-infectious by the protease inhibitor be q,
at
The first three equations are independent of the fourth so it suffices to consider the reduced three-component system (x, y, vj) . At any equilibrium point we will always have »Nl= y where asterisks denote equilibrium values. The critical point P\ is still at (-, 0,0) and this is an attractor if whereas it is a saddle point if this inequality is reversed. The point /^ has coordinates
As before, the condition that P^ be at unphysical values coincides with that for Pi to be an attractor. Relative to the non-treatment values, x* is increased, whereas y* and v* are decreased, which are desired outcomes. However, one may make the viral load vanish with treatments which are less than 100% efficient-it is sufficient that the inequality (16) be satisfied because then solutions tend to P\ where vj = 0, no matter what the values of (*(*o). y(to), vi(to)). It is useful to rearrange (16) to give a critical value of q (efficiency of the protease inhibitor) for extinction of the virus for a given value of r (efficiency of the reverse transcriptase inhibitor). This gives so that if q is greater than q c the virus will be extinguished. These critical values are listed in Table 1 for the standard parameter set Thus one can see that even in the absence of a reverse transcriptase inhibitor (r = 0), the virus is extinguished if q > 0-75, and that even if both of the drugs are only 50% efficient, the virus may be eliminated. Of course these remarks only apply if the threecomponent model employed here is valid.
Conclusions and discussion
We have investigated a general two-component virus-antibody dynamical system and models for early HTV-1 population dynamics which incorporate either two, three or four components. Such models have proven useful in understanding the clinical time course of -l infection and with modifications have been used to investigate various regimes of drug therapy. In each model there are always two critical (equilibrium) points, one of which may not be at biologically meaningful values of the dynamical variables. The behavior of solutions is broadly only of two types; either the critical point P\ at zero virion density is an attractor and all solutions end up at P\; or P\ is an unstable saddle point and all solutions end up at the other critical point,/*2, which may be a spiral point or a node, at non-zero virion levels. There is in fact a transcritical bifurcation as parameters pass through critical values. For the three-component HTV-1 model, which includes uninfected CD4+ T-cells, infected cells and virions, the parameter values which divide the two kinds of behavior are found analytically. If ay < ks ( -c~°) , then Pi is an unstable saddle point and Pi is either a node or spiral point. Otherwise, P2 is at unphysical values and Pi is an asymptotically stable node or spiral point In these systems, which are only weakly non-linear, we have not found any periodic solutions in the absence of additional forcing terms. Perelson et aL (1993) had also found an absence of periodic solutions for the usual parameter ranges, but demonstrated the occurrence of a Hopf bifurcation at parameter values beyond such ranges. For the 4-component HIV-1 dynamical model, which includes both latently and actively infected CD4+ T-cells, we have obtained expressions for the positions of the critical points and investigated solution properties for various parameter values. The properties of the solutions of the more complicated 4-component model are not very qualitatively different from those of the simpler 2-and 3-component models, despite the fact that the additional parameters in the 4-component model have clear biological interpretations. We have illustrated the effects of treatment with certain classes of drugs, in particular reverse transcriptase inhibitors and protease inhibitors, by using the threecomponent HTV-1 model. We have seen that in this framework the virus could be eliminated with various values for the efficiencies of the two treatments. However, it is again pointed out that the model is only supposed to be a reasonable representation for the early period after HTV-1 infection. As pointed out by Ferguson et aL (1999) , additional factors need to be accounted for in the quest for satisfactory long-term therapy.
